Does cardiopulmonary exercise testing provide prognostic value and assess functional capacity in patients with cardiac amyloidosis?
Cardiopulmonary exercise testing provides valuable prognostic and functional information in patients with cardiac amyloidosis.
In CA, CPET is helpful in assessing functional capacity, circulatory and chronotropic responses as well as the prognosis of patients along with cardiac biomarkers.
Nicol et al. (Fri,) studied this question.